BRPI0817905A2 - Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas - Google Patents

Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas

Info

Publication number
BRPI0817905A2
BRPI0817905A2 BRPI0817905-0A2A BRPI0817905A BRPI0817905A2 BR PI0817905 A2 BRPI0817905 A2 BR PI0817905A2 BR PI0817905 A BRPI0817905 A BR PI0817905A BR PI0817905 A2 BRPI0817905 A2 BR PI0817905A2
Authority
BR
Brazil
Prior art keywords
bifidobacterium
cup
prevention
preparation
treatment
Prior art date
Application number
BRPI0817905-0A2A
Other languages
English (en)
Inventor
Cecile Aubert-Jacquin
Francis Lecroix
Emmanuel Perrin
Valerie Petay
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0817905(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of BRPI0817905A2 publication Critical patent/BRPI0817905A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0817905-0A2A 2007-10-03 2008-10-02 Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas BRPI0817905A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0706925A FR2921795B1 (fr) 2007-10-03 2007-10-03 Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
PCT/FR2008/001372 WO2009074754A1 (fr) 2007-10-03 2008-10-02 Utilisation d'une souche de bifidobacterium, pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique

Publications (1)

Publication Number Publication Date
BRPI0817905A2 true BRPI0817905A2 (pt) 2014-10-07

Family

ID=39580478

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817905-0A2A BRPI0817905A2 (pt) 2007-10-03 2008-10-02 Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas

Country Status (11)

Country Link
US (1) US9707258B2 (pt)
EP (1) EP2197287B1 (pt)
CN (2) CN101848643A (pt)
AR (1) AR068726A1 (pt)
BR (1) BRPI0817905A2 (pt)
ES (1) ES2782375T3 (pt)
FR (1) FR2921795B1 (pt)
MY (1) MY168203A (pt)
PL (1) PL2197287T3 (pt)
RU (1) RU2522282C2 (pt)
WO (1) WO2009074754A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011121379A1 (en) * 2010-03-30 2011-10-06 Assistance Publique - Hopitaux De Paris Use of bifidobacteria for preventing allergy in breastfed infants
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
CN103582423A (zh) * 2010-11-11 2014-02-12 雀巢产品技术援助有限公司 含非复制性益生菌微生物的可勺性酸奶制备物
WO2012135081A2 (en) 2011-03-25 2012-10-04 Children's Medical Center Corporation Lin28-mediated control of let-7 biogenesis
PL2986157T3 (pl) 2013-04-08 2020-07-27 N.V. Nutricia Fermentowana kompozycja odżywcza z inhibitorem proteazy tiolowej
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017365019A1 (en) 2016-11-23 2019-07-11 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2019212329A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with specific beta-lactoglobulin peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
FR2795917B1 (fr) * 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
JP4521687B2 (ja) * 2002-06-21 2010-08-11 ニューキャッスル イノベーション リミテッド プロバイオティクス、プロピオニバクテリウム・イエンセニー７０２
KR100507417B1 (ko) * 2003-01-27 2005-08-10 (주) 피엘바이오 알레르기 질환 예방 및 치료 기능을 가진 유산균과 이를 함유한 항알레르기 제품
US20050175630A1 (en) * 2003-12-23 2005-08-11 Eyal Raz Immunogenic compositions and methods of use thereof

Also Published As

Publication number Publication date
CN105724570A (zh) 2016-07-06
RU2010117248A (ru) 2011-11-10
WO2009074754A1 (fr) 2009-06-18
US9707258B2 (en) 2017-07-18
RU2522282C2 (ru) 2014-07-10
EP2197287A1 (fr) 2010-06-23
FR2921795B1 (fr) 2011-04-29
EP2197287B1 (fr) 2020-01-08
US20100221226A1 (en) 2010-09-02
PL2197287T3 (pl) 2020-11-16
MY168203A (en) 2018-10-15
ES2782375T3 (es) 2020-09-14
FR2921795A1 (fr) 2009-04-10
CN101848643A (zh) 2010-09-29
AR068726A1 (es) 2009-12-02

Similar Documents

Publication Publication Date Title
BRPI0817905A2 (pt) Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas
IL250641B (en) Pharmaceutical preparations for inhibiting nhe-mediated antiport in the treatment of disorders related to fluid retention or salt overload and disorders in the digestive system
BRPI0819799A2 (pt) Composto, intermediário, uso de um composto, composição farmacêutica, e, método para prevenir, tratar ou melhorar uma doença
BRPI0717697A2 (pt) composto, composição farmaceutica, uso do composto, método para tratar um paciente sofrendo de uma condição patológica ou uma doença e combinação de produtos
ES2525801T8 (es) Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes
BRPI0811111A2 (pt) composição farmacêutica oronasofaringeamente liberável para a prevenção/alívio e/ou tratamento do distúrbio de membros inquietos
BRPI0817028A2 (pt) composto inibidor de diacilglicerol acil tranferase, composição farmacêutica que o contém, uso do composto, métodos para o tratamento ou profilaxia de diabetes, obesidade, distúrbios de alimentação e dislidemias e diabetes do tipo ii
BRPI0909985A2 (pt) Composição farmacêutica e método para o tratamento ou profilaxia de uma infecção viral ou doença associada à mesma
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BRPI0814825A2 (pt) Composto, processo para a preparação do composto, composição farmacêutica que o compreende, seu uso e métodos para o tratamento ou profilaxia de diabetes, obesidade, distúrbios de alimentação ou dislipimedia e diabetes do tipo ii
BRPI0920272A2 (pt) composição de filtro-solar, método para melhorar a resistência à água de uma composição de filtro-solar, método para melhorar a eficácia de filtro-solar, e, formulação de filtro-solar
BRPI1009034A2 (pt) composição farmacêutica e método para o tratamento ou profilaxia de uma infecção viral ou doença associada a mesma
BRPI1013763A2 (pt) Composto ou sal do mesmo, prodroga, composição farmacêutica, agente diminuidor da proteína de ligação de retinol 4, agente para a profilaxia ou tratamento de diabetes, e, uso de um composto
CL2012000487A1 (es) Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.
AP2965A (en) Therapeutic compositions and the use thereof
BRPI1008974A2 (pt) composto, composição farmacêutica, e, método para tratar, prevenir ou melhorar uma doença mediada com gsk-3
AP2490A (en) Therapeutic compositions and the use thereof
BRPI1014081A2 (pt) uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma
HK1166983A1 (zh) 包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途
CL2007002920A1 (es) Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
BRPI0816814A2 (pt) composto, composição farmacêutica, método para tratar, prevenir ou melhorar uma doença mediada por gsk-3, uso de um composto, e, artigo de fabricação.
BRPI0911019A2 (pt) "composição farmacêutica, especialidade farmacêutica, progesterona micronizada em óleo de cártamo de tipo ii e uso da progesterona micronizada em cártamo óleo de tipo ii"
BRPI0911203A2 (pt) peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo.
IL218644A0 (en) Pharmaceutical composition having the active substances metformin and sitaglipin or vildagliptin
BRPI1011768A8 (pt) agentes para o tratamento e/ou profilaxia de um distúrbio, e de uma doença, composição farmacêutica, kit, derivado de tiazol, composto, combinação, e, uso de um derivado de tiazol

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/745 (2015.01), A23C 9/123 (2006.01), A23C

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL